{"id":"W4367397422","doi":"10.1016/j.ejca.2023.04.016","title":"Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; Merck","keywords":"Pembrolizumab; Medicine; Metformin; Placebo; Stage (stratigraphy); Internal medicine; Oncology; Predictive value; Cancer; Phases of clinical research; Clinical trial; Immunotherapy; Pathology; Alternative medicine; Insulin; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002614348,0.0001337581,0.000349858,0.0002087482,0.00004456694,0.00001271069,0.0001807406,0.00003701497,0.00001411542],"category_scores_gemma":[0.0003061914,0.00009449746,0.00006260951,0.0002533227,0.0001731471,0.00001448309,0.00005406099,0.0001322716,1.653065e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005515672,"about_ca_system_score_gemma":0.0002472778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002623417,"about_ca_topic_score_gemma":0.0003163489,"domain_scores_codex":[0.9974473,0.00119773,0.0006147235,0.0002031497,0.0003163047,0.0002208469],"domain_scores_gemma":[0.9987484,0.0002183631,0.0005159014,0.0001773993,0.000280794,0.00005910217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4090254,0.001082819,0.007371283,0.0002651626,0.001087665,0.00007540207,0.01263755,0.001539552,0.1206787,0.0001021509,0.0009127872,0.4452215],"study_design_scores_gemma":[0.5514911,0.04207011,0.08590806,0.0004399631,0.0006580553,0.000006414129,0.004673287,0.0005767044,0.2909158,0.0001174866,0.02274642,0.0003966462],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722981,0.02622497,0.00003851899,0.00003101665,0.0002080363,0.0007589314,0.0002516019,0.00000174382,0.0001870974],"genre_scores_gemma":[0.95026,0.04917131,0.00004292681,0.000005461749,0.0003740751,0.00003179967,0.00002212669,0.00002826179,0.00006407688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4448249,"threshold_uncertainty_score":0.3853495,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04977394313242677,"score_gpt":0.3597668600185554,"score_spread":0.3099929168861286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}